You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 9,808,377


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,808,377
Title:Fluid extraction or filtration device, associated materials and methods
Abstract: A fluid extraction or filtration device for removing fluid from a body, the device comprising an array of microneedles for contacting fluid in said body and an absorbent gel matrix in fluid communication with said array of microneedles. There is further provided a combined fluid extraction and sampling device and methods employing the device(s), for example in determining the level of a target species in a sample of fluid, transdermal dialysis and renal replacement therapy. There is further provided an absorbent gel matrix for use in the treatment of uraemia and a haemodialysis filter comprising an absorbent gel matrix. Use of such a matrix is described in the context of methods including haemodialysis, transdermal dialysis and gastrointestinal dialysis.
Inventor(s): Mitra; Sandip (Sale, GB), Brenchley; Paul Ernest Charles (Sale, GB), Ulijn; Rein Vincent (Clarkston, GB)
Assignee: Renephra Limited (Manchester, GB)
Application Number:14/063,489
Patent Claims:1. A method of treating fluid overload employing a device comprising an array of microneedles for contacting fluid in a body of a patient and an absorbent matrix in fluid communication with said array of microneedles, the method comprising contacting said fluid with said array of microneedles such that said fluid flows from said body to said absorbent matrix via said microneedles; and removing fluid from the body of the patient at a rate of at least 10 ml/day and up to 1000 ml/day.

2. The method according to claim 1 wherein the fluid overload results from renal failure or cardiac failure.

3. The method according to claim 1 wherein said method treats salt and water overload in said patient.

4. The method according to claim 1 wherein fluid is removed from the body of the patient at a rate of at least 50 ml/day.

5. The method according to claim 1 wherein fluid is removed from the body of the patient at a rate of at least 100 ml/day.

6. The method according to claim 1 wherein the method further comprises use of a vacuum suction device to accelerate the flow of fluid from said body to said absorbent matrix via said microneedles.

7. The method according to claim 1 wherein the method further comprises using reverse iontophoresis to aid the flow of fluid from said body to said absorbent matrix via said microneedles.

8. The method according to claim 1 wherein the absorbent matrix is a gel.

9. The method according to claim 1 wherein an osmotic gradient is established between the fluid and the absorbent matrix such that said fluid flows, by osmosis, from said body to said absorbent matrix via said microneedles.

10. The method according to claim 1 wherein the absorbent matrix is dry prior to contacting the fluid.

11. The method according to claim 1 wherein the absorbent matrix exhibits an ability to entrap up to 30 times its own weight of water.

12. The method according to claim 1 wherein the absorbent matrix exhibits an ability to entrap water of up to 90% w/w.

13. The method according to claim 1 wherein said fluid comprises a target species, said patient being in need of having said target species removed from said fluid and said target species being retained in said absorbent matrix.

14. The method according to claim 13 wherein said target species is selected from the group consisting of water, a uraemic toxin, a metabolic product, a salt and an ion.

15. The method according to claim 13 wherein said target species is selected from the group consisting of Retinol Binding Protein, beta-2-Microglobulin, Parathyroid hormone, Adrenomedullin, Atrial Natriuretic Peptide, Asymmetric dimethylarginine, Indole-3-Acetic acid, Uric acid, Homocysteine, Creatine, Creatinine, P-Cresol, Oxalate, Urea and Phosphate.

16. The method according to claim 1 wherein the method is used for treatment of uraemia; and wherein said patient suffers from uraemia; and wherein said fluid that flows from said body to said absorbent matrix via said microneedles contains one or more uraemic toxin.

17. A method for transdermal dialysis employing a device comprising an array of microneedles for contacting fluid in a body of a patient in need of dialysis and an absorbent matrix in fluid communication with said array of microneedles, the method comprising: contacting said fluid with said array of microneedles such that fluid flows from said body to said absorbent matrix via said microneedles, and removing fluid from the body of the patient at a rate of at least 10 ml/day and up to 1000 ml/day.

18. A method for renal replacement therapy comprising transdermal dialysis employing a device comprising an array of microneedles for contacting fluid in a body of a patient in need of renal replacement therapy and an absorbent matrix in fluid communication with said array of microneedles, the method comprising: contacting said fluid with said array of microneedles such that fluid flows from said body to said absorbent matrix via said microneedles, and removing fluid from the body of the patient at a rate of at least 10 ml/day and up to 1000 ml/day.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.